Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans his Department has to hold discussions with the Reclassification Alliance on the future of medicines reclassification.

The Medicines and Healthcare products Regulatory Agency (MHRA) chairs the Reclassification Alliance, a collaborative forum involving the Department of Health and Social Care (DHSC), Proprietary Association of Great Britain (PAGB), pharmacy bodies and industry stakeholders.

The Alliance was relaunched in July 2023 to explore opportunities for improving the reclassification of medicines in the UK. Although the next meeting has not yet been scheduled, the work of the Alliance remains ongoing. MHRA is working with industry to encourage the application of new therapies for consideration in the over-the-counter setting.

As part of this work, the MHRA has developed an updated reclassification procedure and, in April 2024, published updated reclassification guidance. The MHRA also held a reclassification webinar for industry on 12 November 2024 which focused on the updated procedure and the recently published reclassification guidance.

Further information on the Government’s priorities for reclassification, including the list of conditions and categories identified for potential reclassification, is available at the following link: https://healthmedia.blog.gov.uk/2025/02/05/new-opportunities-to-reclassify-medicines-what-you-need-to-know